Michael D. Harvey - Chief Development Officer @ Congruence Therapeutics

Overview

CB Rank (Person)

Primary Job Title Chief Development Officer
Primary Organization
Congruence Therapeutics

Location Montréal, Quebec, Canada
Gender Male

LinkedIn View on LinkedIn

Michael D. Harvey is the current Chief Development Officer (CDO) of Congruence Therapeutics. He previously worked at Clementia Pharmaceuticals Inc. as a Vice President. Michael D. Harvey attended Concordia University.

Jobs

Number of Current Jobs

Michael D. Harvey

has

current jobs as

Chief Development Officer

Congruence Therapeutics

and

Chief Development Officer

Inversago Pharma

Congruence Therapeutics Chief Development OfficerApr 2024
Inversago Pharma Chief Development OfficerOct 2021

Related Hubs

Hub Name	CB Rank (Hub)
Montréal Companies With Less Than $10M in Revenue	8,882
BDC Venture Capital Portfolio Companies	52,368
Montréal Companies With Fewer Than 100 Employees	5,529
Montréal Companies	3,145
Private Montréal Companies	3,268
Canada Biotechnology Companies	16,982
Quebec Biotechnology Companies	41,988
Montréal Companies With More Than 10 Employees	8,891
Investissement Quebec Portfolio Companies	74,244
Montréal Companies With Less Than $500M in Revenue	7,122

Education

Michael D. Harvey

studied at

Concordia University

and

Concordia University

Concordia University B.ScBiology19931996
Concordia University Ph.D.Chemistry19962001

Recent News and Activity

There is no recent news or activity for this profile.